- Home
- ABAT vs OPTN Comparison
ABAT vs OPTN Comparison
Compare ABAT & OPTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ABAT
- OPTN
- Stock Information
- Founded
- ABAT 2011
- OPTN 2010
- Country
- ABAT United States
- OPTN United States
- Employees
- ABAT N/A
- OPTN N/A
- Industry
- ABAT Metal Mining
- OPTN Biotechnology: Pharmaceutical Preparations
- Sector
- ABAT Basic Materials
- OPTN Health Care
- Exchange
- ABAT Nasdaq
- OPTN Nasdaq
- Market Cap
- ABAT 71.7M
- OPTN 78.4M
- IPO Year
- ABAT N/A
- OPTN 2017
- Fundamental
- Price
- ABAT $0.98
- OPTN $0.45
- Analyst Decision
- ABAT
- OPTN Strong Buy
- Analyst Count
- ABAT 0
- OPTN 3
- Target Price
- ABAT N/A
- OPTN $3.00
- AVG Volume (30 Days)
- ABAT 586.7K
- OPTN 1.2M
- Earning Date
- ABAT 11-15-2024
- OPTN 11-12-2024
- Dividend Yield
- ABAT N/A
- OPTN N/A
- EPS Growth
- ABAT N/A
- OPTN N/A
- EPS
- ABAT N/A
- OPTN N/A
- Revenue
- ABAT $545,460.00
- OPTN $75,672,000.00
- Revenue This Year
- ABAT $31,748.62
- OPTN $13.42
- Revenue Next Year
- ABAT N/A
- OPTN $52.99
- P/E Ratio
- ABAT N/A
- OPTN N/A
- Revenue Growth
- ABAT N/A
- OPTN 5.13
- 52 Week Low
- ABAT $0.73
- OPTN $0.32
- 52 Week High
- ABAT $6.45
- OPTN $2.10
- Technical
- Relative Strength Index (RSI)
- ABAT 61.18
- OPTN 39.55
- Support Level
- ABAT $0.83
- OPTN $0.42
- Resistance Level
- ABAT $1.08
- OPTN $0.57
- Average True Range (ATR)
- ABAT 0.09
- OPTN 0.05
- MACD
- ABAT 0.01
- OPTN 0.00
- Stochastic Oscillator
- ABAT 57.32
- OPTN 26.39
About ABAT American Battery Technology Company
American Battery Technology Co is engaged in lithium-ion battery recycling, battery metals and material extraction, and resource production. It is a battery metals company producing low-cost battery metals with a commitment to closed-loop, clean energy technologies.
About OPTN OptiNose Inc.
OptiNose Inc is a specialty pharmaceutical company focuses on the development and commercialization of products for patients treated by ear, nose, and throat (ENT), and allergy specialists. Its first commercial product, XHANCE (fluticasone propionate) nasal spray, 93 microgram (mcg), is a therapeutic utilizing the proprietary Exhalation Delivery System (EDS) that delivers a topically-acting corticosteroid for the treatment of chronic rhinosinusitis with and without nasal polyps.